Not admitted · Vague or promotional

Data presented at AACAP 2024 showing SSRIs and other antidepressants reduce height growth in children and adolescents (consistent with TORDIA), on top of weight gain. The author frames it as another blow against pediatric antidepressant use, contrasting Neuronetics' NeuroStar TMS FDA clearance for ages 15 to 21 as an adjunct to psychotherapy.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.